Start with your numbers.
Get an initial range and a clearer starting point for your plans.
How to sell a DME business, start to finish.
2.8x-3.3x
SDE multiple, sold deals
3.1x
Typical multiple
3.7x-4.4x
At $1,000,000 of SDE
3.5x-5.8x
EBITDA on larger sales
The SDE figures are from our sold-deal dataset (source: BizBuySell's medical supply benchmarks). These ranges come from small sales. From $250,000 of SDE our calculator raises an industry's range with size, up to 1.32 times at $1,000,000 of SDE. Online businesses and the types whose sales often include the property keep their ranges. Figures checked November 2, 2026. Every industry is on our valuation multiples page.
The EBITDA figure is IBBA Market Pulse's closed-deal range across all industries, for sales of $2,000,000 and up. We hold no sold EBITDA series for DME alone. EBITDA is profit after paying a manager, so it doesn't apply to an SDE figure.
More people are reaching the age when they need this equipment. The Census Bureau wrote in 2019 that about 10,000 people a day had been turning 65 since 2010, and that by 2030 every baby boomer will be at least 65.
Larger home medical equipment companies buy independents to add territory, referral relationships and product lines.
Recurring revenue draws buyers. Rental fleets and CPAP resupply programs are revenue a buyer can forecast.
Medicare's competitive bidding program has been in a temporary gap period since January 1, 2024. CMS is preparing its next round, Round 2028, so buyers will ask how much of your revenue sits in the product categories it covers.
Running an independent is complex: payer audits, prior authorization rules and billing technology all take work. That leads some owners to sell, and it makes a well-run independent useful to a buyer that already has those systems.
Owner-run DME businesses are valued on Seller's Discretionary Earnings (SDE): your profit plus your salary and the personal expenses that run through the business. A buyer multiplies your SDE by a number (the "multiple") to get your value. Smaller owner-run businesses are priced on SDE and larger ones on EBITDA: our calculator uses SDE under $1,000,000 of yearly owner earnings, EBITDA (SDE less a $150,000 manager's salary) from $2,000,000, and a blend of the two in between.
Recurring revenue is the foundation of a DME valuation. Rental income and resupply programs repeat. One-time equipment sales are valued like retail. The same dollar of profit is worth more when it repeats every month.
Billing quality is checked line by line. Buyers look at denial rates, how fast you collect, and your audit history, because in DME, revenue on paper isn't revenue until the claim is paid.
Compliance carries real weight. Current accreditation, clean payer audits, complete medical necessity paperwork and an active surety bond are the minimum. Gaps here don't just lower the price. They can end the deal.
Smaller owner-run businesses are priced on SDE and larger ones on EBITDA: our calculator uses SDE under $1,000,000 of yearly owner earnings, EBITDA (SDE less a $150,000 manager's salary) from $2,000,000, and a blend of the two in between.
Across all industries, sales of $2,000,000 to $5,000,000 closed at about 4.0x EBITDA (3.5x to 4.1x) and sales of $5,000,000 and up closed at about 4.9x EBITDA (4.0x to 5.8x) in IBBA Market Pulse's closed-deal data. EBITDA is profit after paying a manager, a different yardstick from an SDE multiple.
See sold multiples by size or read how a dedicated advisor runs your sale.
Two DME companies with the same profit can sell for very different prices. These four factors explain most of the gap. For the range at four sizes and a worked example, see our DME business valuation guide.
Medicare calls this industry DMEPOS: durable medical equipment, prosthetics, orthotics and supplies. A supplier has to be accredited by a CMS-approved organization (ACHC, CHAP, The Joint Commission and others) to enroll and bill, and has to meet Medicare's supplier standards, surety bond included. Buyers check these before anything else. A company with current accreditation, a documented compliance program and a clean history with payer audits is ready to buy. A company with lapsed accreditation or open audit findings is a project, and buyers price projects that way. Strong billing operations (low denial rates, tight prior authorization steps, receivables collected quickly) move you up the range on their own.
A balanced book across Medicare, commercial insurance and cash retail is the ideal. Heavy dependence on one payer compresses the multiple, because one fee schedule change can reshape your economics. Cash and retail revenue (home accessibility, compression, bracing, retail CPAP supplies) carries no payer audit risk and no fee schedule risk. If you can show a payer mix where no one program brings in most of your revenue, you take away one of the buyer's biggest reasons to discount.
Buyers will map where your orders come from: physician practices, hospital discharge planners, sleep labs, wound care clinics, home health agencies. If one referral source brings in a large share of revenue, expect the offer to reflect that risk, often with part of the price held back in an earnout tied to keeping that source. Referrals spread across many prescribers, and relationships that belong to the company instead of to you, protect your price.
This is the driver owners often underrate. Rental revenue (oxygen equipment, hospital beds, wheelchairs) repeats month after month, and resupply programs (CPAP masks, tubing, filters, ostomy and urology supplies) repeat on a schedule. Buyers can forecast that revenue, so they pay more for it. One-time equipment sales start from zero every month. A business where most revenue comes from rentals and resupply tends to sell higher in the range than one built on one-time sales. If your resupply reorder rates are strong, document them. They're a selling point.
Wondering how much your DME business is worth?
Our free calculator takes about 2 minutes. It asks for your yearly sales, profit, years in business, growth and how much of your sales your biggest customer brings in. Your range shows first. Your exact number comes with your details.
Get my free valuationFour main buyer types, and how each one prices a company:
Private equity groups building regional and national home medical equipment companies buy independents to add territory, referral networks and resupply books. They price larger companies on EBITDA: across all industries, larger sales closed at 3.5x-5.8x EBITDA in IBBA Market Pulse's data. At $500,000 of SDE, our calculator's range for DME is 3.1x-3.7x SDE.
Priced on SDE, in the 2.8x-3.3x sold range for small businesses. Existing operators expanding into your service area or adding a product line (sleep, mobility, respiratory) they don't carry. They already know accreditation and payer enrollment.
Home health agencies, infusion companies, pharmacies and medical supply distributors adding DME to what they offer. They value your referral relationships, your payer contracts and a service area that fits theirs.
Priced on SDE, in the 2.8x-3.3x sold range for small businesses. Healthcare professionals and first-time buyers, often with SBA financing. Simpler deals, but in an asset sale the buyer's new payer enrollment needs careful transition planning.
Across all four buyer types, due diligence in DME comes down to the same questions. Can the revenue be checked claim by claim? Will the referral sources keep ordering after the owner leaves? Is the billing compliant enough to survive an audit? And how much of the revenue repeats without new sales effort? If you can answer all four with documents instead of promises, you've answered what buyers most want to know.
Not sure which buyer type fits your company? Start with your free valuation. If your company earns $700,000 or more a year in profit, you can also book a call with a dedicated advisor.
Structure matters a lot in DME because your Medicare billing number, accreditation and payer contracts don't follow the assets. Here's what to expect:
In many small-business sales, buyers prefer to buy assets, for tax and liability reasons. DME is different. Medicare's supplier standards say a supplier can't convey or reassign its billing number (PTAN). So in an asset sale the buyer needs its own Medicare enrollment, its own accreditation and new payer contracts, which takes time and can leave a gap in billing. In a stock sale the enrolled company stays the same, so the number, accreditation and contracts generally stay in place, and the change in ownership is reported to Medicare.
Because of this, many DME deals are done as stock sales, sometimes with indemnities and escrows to protect the buyer from billing problems that date from before closing. If your buyer insists on an asset sale, plan the enrollment timeline early: the gap between closing and the buyer's first paid claim is a real negotiating point. Your healthcare attorney and your accountant should both weigh in before you sign a letter of intent. Our guide to asset sales and stock sales covers the basics.
DME businesses with clean books and cash flow a lender can check may qualify for SBA 7(a) acquisition loans. The SBA says the maximum 7(a) loan is $5,000,000. That matters to you as a seller because SBA financing widens your buyer pool: an individual buyer can purchase with a down payment and an SBA-backed loan. Lenders will look closely at your payer audit history and revenue concentration, one more reason to clean those up before going to market.
Part of the price is often deferred. A seller note (you lend the buyer part of the price) tells the buyer and their lender that you believe in the business. SBA lenders have their own rules for seller notes, so ask the lender early. Earnouts show up when a buyer worries about keeping your referrals: part of the price is paid only if revenue from key referral sources holds for a set time after closing. Earnouts are negotiable, and your best defense is the referral base you spread out before listing. Our DME preparation guide covers how to do that in the year before a sale.
A dedicated advisor runs your sale for a success fee set for your business and paid only at closing. There's no retainer, no upfront cost and no monthly fee, and it's in writing before you sign. See how our pricing works.
Your exit credit comes off our success fee at closing and grows with your yearly sales: $5,000 under $5,000,000 in sales ($2,500 for your valuation report, plus $2,500 for your advisor call or for starting your listing), up to $50,000 at $100,000,000 or more. Booked calls start at $700,000 a year in profit.
Start with our free valuation calculator. It takes about 2 minutes. Your range shows first. Your exact number comes with your details. Knowing your range first keeps you from anchoring to a low unsolicited offer.
You'll need an M&A advisor or DME business broker experienced in healthcare deals, a healthcare attorney for the purchase agreement and the change of ownership or enrollment filings, and your accountant to prepare clean financials and model the tax difference between an asset and a stock sale. DME deals can fail on regulatory details as easily as on price, so go to market with advisors who have seen these deals before.
Buyers will ask for:
In the 6 to 12 months before you sell, grow resupply enrollment, collect old AR, renew accreditation and licenses so nothing expires mid-deal, and spread referral relationships across your team. Each one helps move you up the range. The full checklist is in our DME business preparation guide.
Your advisor lists the business confidentially: buyers see the financial picture, not your company name, location or referral relationships. On BridgeBook's marketplace, a buyer signs an NDA for your listing and confirms their email before they can see your business name. This matters in DME: if referral sources or competitors learn you're selling before the deal is done, orders can shift elsewhere. Serious buyers review your information and send a letter of intent (LOI) with price and structure.
Once you accept an LOI, the buyer checks everything: billing samples against medical necessity paperwork, payer contracts, accreditation status, rental fleet counts, referral source data and employment agreements. Due diligence on a DME deal often takes a few months, and longer if the structure needs new payer enrollment.
Then the regulatory work closes out: change of ownership filings or new enrollment, state license transfers and payer notices. Sellers usually stay on for a transition period, and buyers often ask the owner to introduce them to top referral sources in person. For the sale process in any industry, see our guide on how to sell a business.
DME deals that fail often fail in due diligence. These issues can end a deal after the LOI:
The buyer samples claims and finds missing physician orders, expired prior authorizations or proof of delivery gaps. In DME, paperwork problems read as repayment risk, and buyers walk.
A Medicare audit that surfaces mid-diligence is far worse than one disclosed up front with a clean ending. Disclose early, with context.
The listing said "diversified referrals" but due diligence shows one sleep lab sending a large share of orders. Now the price gets rebuilt around an earnout, and trust is damaged.
A lapse during due diligence can pause billing and worry lenders. Renew everything before you list, even if it feels early.
If a large part of your receivables is old, buyers treat it as worthless and reprice. Collect or write off old AR before going to market.
If every referral source knows only you, buyers fear the revenue leaves with you. A named second contact for each key account takes that fear away.
Plan on 6 to 12 months from preparation to closing. These are planning ranges, not sold-deal statistics. Here's how the time usually breaks down:
Valuation, financial cleanup, gathering documents, and fixing the issues buyers will find anyway. Time spent here shortens everything that follows.
The listing goes live with your name hidden, NDAs get signed, buyers review the data, and offers come in.
Due diligence, the purchase agreement, financing approval, and the regulatory filings: change of ownership or new enrollment, license transfers and payer notices. Stock sales usually move faster here than asset sales.
Two choices affect the clock more than anything else. First, deal structure: an asset sale that needs the buyer to get new Medicare enrollment and accreditation can add months compared with a stock sale. Second, preparation: sellers who show up with organized financials, current accreditation and a clean audit file tend to close faster than sellers who gather documents on demand.
DME businesses sell for 2.8x-3.3x their yearly owner profit (SDE) in sold-deal data, with 3.1x as the typical multiple. The range rises with size: at $500,000 of SDE our calculator shows $1,538,267 to $1,842,600. Recurring rental and resupply revenue, current Medicare accreditation, a balanced payer mix and a spread-out referral base move you up the range. Smaller owner-run businesses are priced on SDE and larger ones on EBITDA: our calculator uses SDE under $1,000,000 of yearly owner earnings, EBITDA (SDE less a $150,000 manager's salary) from $2,000,000, and a blend of the two in between. Our free calculator shows your range first, and your exact number comes with your details.
It depends on the deal structure. Medicare's supplier standards say a supplier can't convey or reassign its billing number (PTAN), so it can't be sold with the assets. In a stock sale the enrolled company stays the same, so the PTAN, accreditation and payer contracts generally stay in place, and the change in ownership is reported to Medicare. In an asset sale the buyer usually needs its own enrollment and accreditation, which can leave a gap in billing if it isn't planned early. That's why many DME buyers and sellers look hard at a stock sale.
Plan on 6 to 12 months from preparation to closing, and longer if the buyer has to enroll with Medicare from scratch. Payer enrollment, accreditation and state licensing are the usual sources of delay, especially in an asset sale. Well-documented companies with clean billing audits give buyers less to slow down on.
Yes, it moves you up the range. Rentals (oxygen equipment, hospital beds, wheelchairs) and resupply programs (CPAP masks, tubing, filters) repeat, and buyers pay more for revenue they can forecast. A DME business where most revenue recurs tends to sell higher in the 2.8x-3.3x SDE range than one built on one-time equipment sales.
You can sell on your own, but a DME sale involves payer enrollment, accreditation, billing compliance checks and buyer screening that most owners have never handled. An advisor who knows healthcare deals runs the process confidentially: your company name, location and referral relationships stay hidden until a buyer signs an NDA. With BridgeBook, a dedicated advisor runs your sale for a success fee set for your business and paid only at closing, with no retainer or upfront fee, in writing before you sign.
Free. About 2 minutes. Your range shows first. Your exact number comes with your details.
Your exit credit comes off our success fee at closing and grows with your yearly sales: $5,000 under $5,000,000 in sales ($2,500 for your valuation report, plus $2,500 for your advisor call or for starting your listing), up to $50,000 at $100,000,000 or more.
Get an initial range and a clearer starting point for your plans.
Discuss your goals, timing and questions in a private conversation.